MedTrace Logo

A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects

NCT02113020 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2014-10-21

No results posted yet for this study

Summary

The objective of this clinical trial is to examine the clinical pharmacology properties of TAK-233 in healthy female subjects

Conditions

  • Clinical Pharmacology

Interventions

DRUG

TAK-233

Oral administration of TAK-233

DRUG

Placebo

Oral admininstration of Placebo

Sponsors & Collaborators

Principal Investigators

  • General Manager · Takeda

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02113020 on ClinicalTrials.gov